- Home
- CRDF vs BRBS Comparison
CRDF vs BRBS Comparison
Compare CRDF & BRBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- BRBS
- Stock Information
- Founded
- CRDF 1999
- BRBS 1893
- Country
- CRDF United States
- BRBS United States
- Employees
- CRDF N/A
- BRBS N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- BRBS Commercial Banks
- Sector
- CRDF Health Care
- BRBS Finance
- Exchange
- CRDF Nasdaq
- BRBS Nasdaq
- Market Cap
- CRDF 240.2M
- BRBS 284.6M
- IPO Year
- CRDF N/A
- BRBS N/A
- Fundamental
- Price
- CRDF $3.45
- BRBS $3.35
- Analyst Decision
- CRDF Strong Buy
- BRBS
- Analyst Count
- CRDF 3
- BRBS 0
- Target Price
- CRDF $10.33
- BRBS N/A
- AVG Volume (30 Days)
- CRDF 1.4M
- BRBS 224.4K
- Earning Date
- CRDF 02-27-2025
- BRBS 01-29-2025
- Dividend Yield
- CRDF N/A
- BRBS N/A
- EPS Growth
- CRDF N/A
- BRBS N/A
- EPS
- CRDF N/A
- BRBS N/A
- Revenue
- CRDF $688,000.00
- BRBS $97,608,000.00
- Revenue This Year
- CRDF $25.03
- BRBS N/A
- Revenue Next Year
- CRDF N/A
- BRBS N/A
- P/E Ratio
- CRDF N/A
- BRBS N/A
- Revenue Growth
- CRDF 49.57
- BRBS N/A
- 52 Week Low
- CRDF $1.44
- BRBS $2.33
- 52 Week High
- CRDF $6.42
- BRBS $3.69
- Technical
- Relative Strength Index (RSI)
- CRDF 45.05
- BRBS 55.23
- Support Level
- CRDF $3.33
- BRBS $3.21
- Resistance Level
- CRDF $4.89
- BRBS $3.43
- Average True Range (ATR)
- CRDF 0.31
- BRBS 0.09
- MACD
- CRDF -0.15
- BRBS 0.01
- Stochastic Oscillator
- CRDF 10.56
- BRBS 60.61
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").
About BRBS Blue Ridge Bankshares Inc.
Blue Ridge Bankshares Inc is a United States-based company engaged in offering commercial and consumer banking and financial services through its wholly-owned bank subsidiary, Blue Ridge Bank, National Association, and its non-bank financial services affiliates. The bank offers services such as checking accounts, savings accounts, money market accounts, cash management accounts, commercial and industrial loans, residential mortgages, commercial mortgages, home equity loans, consumer installment loans, investment accounts, insurance, credit cards, online banking, telephone banking, mobile banking, and other activities to other businesses, professionals, consumers, nonprofits, and municipalities. Its primary source of revenue is interest income from the lending activities.